Skip to main content

Peer Review reports

From: Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

Original Submission
14 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Mar 2022 Reviewed Reviewer Report
3 Apr 2022 Reviewed Reviewer Report - Niam Abdulmunim Al-thanoon
8 Apr 2022 Author responded Author comments - Emmanuelle Leray
Resubmission - Version 3
8 Apr 2022 Submitted Manuscript version 3
11 Apr 2022 Author responded Author comments - Emmanuelle Leray
Resubmission - Version 4
11 Apr 2022 Submitted Manuscript version 4
17 Apr 2022 Reviewed Reviewer Report - Niam Abdulmunim Al-thanoon
24 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
25 Apr 2022 Editorially accepted
30 May 2022 Article published 10.1186/s12874-022-01623-8

You can find further information about peer review here.

Back to article page